HSIF14 · House Subcommittee

Health Subcommittee

House Energy and Commerce Subcommittee on Health

Showing the 116th Congress (2019–2020). Back to the 119th Congress

795 bills referred in the 116th Congress

10,366 across the 13 Congresses on file, most in the 117th at 1,379. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 107th to 119th

Members
49

Served in the 116th Congress

Meetings
36

Hearings and business meetings in the 116th Congress

Members, 116th Congress 49

Everyone listed on the subcommittee in the 116th Congress, from printed hearings, the Congressional Directory and the official rosters.

Record

Bills, meetings, hearings, reports and more, newest first. In the 116th Congress.

Hearings, markups and business meetings, newest first. In the 116th Congress.

KindSubjectStatusDate
HearingThe Fiscal Year 2021 HHS Budget and Oversight of the Coronavirus OutbreakRayburn House Office Building 2123
5 witnesses
  • Dr. Anthony Fauci, Director, National Institute for Allergy and Infectious Diseases, National Institutes of Health
  • The Honorable Stephen Hahn, Commissioner of Food and Drugs, U.S. Food and Drug Administration
  • The Honorable Robert Kadlec, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
  • Dr. Robert Redfield, Director, Centers for Disease Control and Prevention
  • The Honorable Alex Azar, Secretary, U.S. Department of Health and Human Services
RescheduledFeb 26, 2020
Hearing"Protecting Women's Access to Reproductive Health Care"Rayburn House Office Building 2123
5 witnesses
  • Ms. Nancy Northup, President and CEO, Center for Reproductive Rights
  • Dr. Yashica Robinson, Medical Director, Alabama Women’s Center for Reproductive Alternatives
  • Ms. Holly Alvarado, Advocate
  • Ms. Teresa Stanton Collett, Professor of Law
  • Ms. Georgette Forney, President of Anglicans for Life, Co-founder of the Silent No More Awareness Campaign
ScheduledFeb 12, 2020
Hearing“Improving Safety and Transparency in America’s Food and Drugs”Rayburn House Office Building 2322
13 witnesses
  • Mr. J. David Carlin, Senior Vice President of Legislative Affairs and Economic Policy, International Dairy Foods Association
  • Dr. Kao-Ping Chua, Assistant Professor, Department of Pediatrics, University of Michigan Medical School
  • Ms. Melanie Benesh, Legislative Attorney, Environmental Working Group
  • Mr. Tom Balmer, Executive Vice President, National Milk Producers Federation
  • Dr. Douglas Corey, Past President, American Association of Equine Practitioners
  • Ms. Talia Day, Patient Advocate
  • Dr. Paul DeLeo, Principal, Integral Consulting, Inc.
  • Ms. Mardi Mountford, President, Infant Nutrition Council of America
  • Ms. Nancy Perry, Senior Vice President, Government Relations, American Society for the Prevention of Cruelty to Animals
  • Ms. Sara Sorscher, Deputy Director of Regulatory Affairs, Center for Science in the Public Interest
  • Dr. Jeff Allen, President and CEO, Friends of Cancer Research
  • Mr. Richard Kaeser, Vice President, Global Band Protection, Johnson & Johnson
  • Dr. Fernando Muzzio, Distinguished Professor, Chemical and Biochemical Engineering, Rutgers, the State University of New Jersey
ScheduledJan 29, 2020
Hearing"Cannabis Policies for the New Decade"Rayburn House Office Building 2123
3 witnesses
  • Dr. Nora Volkow, Director, National Institute on Drug Abuse, National Institutes of Health
  • Mr. Matthew Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration
  • Dr. Douglas Throckmorton, Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research, Food and Drug Administration
ScheduledJan 15, 2020
Hearing"Legislation to Improve Americans' Health Care Coverage and Outcomes"Rayburn House Office Building 2322
6 witnesses
  • Dr. Matthew Cooper, Director, Kidney and Pancreas Transplantation Medical Director, Transplant QAPI, Medstar Georgetown Transplant Institute Professor of Surgery
  • Mr. Fred Riccardi, President, Medicare Rights Center
  • Ms. Stephanie Zarecky, Mother of Scarlett Pauley, Ambassador Program and Public Relations Manager, SUDC Foundation
  • Mr. Kevin Koser, Patient Advocate
  • Mr. Kenneth Mendez, President and Chief Executive Officer, Asthma and Allergy Foundation of America
  • Dr. Lee Beers, President-Elect, American Academy of Pediatrics
ScheduledJan 8, 2020
HearingProposals to Achieve Universal Health Care CoverageRayburn House Office Building 2322
11 witnesses
  • The Honorable Brian Higgins, Member of Congress
  • The Honorable Pramila Jayapal, Member of Congress
  • The Honorable Antonio Delgado, Member of Congress
  • The Honorable Rosa DeLauro, Member of Congress
  • The Honorable Tom Malinowski, Member of Congress
  • The Honorable Cedric Richmond, Member of Congress
  • Mr. Peter Morley, Patient Advocate
  • Ms. Jean Ross, President, National Nurses United
  • Dr. Douglas Holtz-Eakin, President, American Action Forum
  • Dr. Scott Atlas, David and Joan Traitel Senior Fellow, Hoover Institution, Stanford University
  • Ms. Sara Rosenbaum, Harold and Jane Hirsh Professor of Health Law and Policy, George Washington University Milken Institute School of Public Health
ScheduledDec 10, 2019
Hearing"Building Consumer Confidence by Empowering FDA to Improve Cosmetic Safety"
5 witnesses
  • Ms. M. Isabelle Chaudry, Senior Policy Manager, National Women's Health Network
  • Ms. Leigh O'Donnell, Executive Director, The Handcrafted Soap and Cosmetic Guild
  • Dr. Susan Mayne, Director, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration
  • Ms. Gregg Renfrew, Founder and Chief Executive Officer, Beautycounter, LLC
  • Mr. Scott Faber, Senior Vice President, Government Relations, Environmental Working Group
ScheduledDec 4, 2019
MarkupLegislation on Reducing the Youth Tobacco Epidemic (H.R. 2339) and Improving Maternal Health Quality and Services (H.R. 4995 and H.R. 4996), and H.R. 2387, to clarify process for FDA to deny certain petitions aimed at delaying approval of generic drugs.Rayburn House Office Building 2123ScheduledNov 13, 2019

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredReportedBecame lawMeetings
119th2025–2026, sitting323535225
118th2023–2024301,296901335
117th2021–2022341,379391327
116th2019–202049795371036
115th2017–201834780491750
114th2015–201631773281436
113th2013–201431741131825
112th2011–2012286511360
111th2009–2010397462710—
110th2007–2008338922720—
109th2005–200632815922—
108th2003–200481746522—
107th2001–2002337171112—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.